TABLE 1
FROM:
Commentary: From Scarcity to Abundance: Pandemic Vaccines and Other Agents for "Have Not" Countries
David S Fedson and Peter Dunnill
BACK TO ARTICLETable 1. Formulating a pandemic vaccine that is adequately immunogenic for a population
 g HA per dose
| % with neuttiter  1:40
| Number vaccinated | Number protected |
|---|---|---|---|
| 90 | 54 | 100 | 54 |
| 45 | 43 | 200 | 86 |
| 15 | 22 | 600 | 132 |
| 7.5 | 9 | 1,200 | 108 |
Adapted from reference (17). See text for details.
